Narcolepsy and the hypocretin system—where motion meets emotion
- 22 September 2006
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Neurology
- Vol. 2 (10) , 548-556
- https://doi.org/10.1038/ncpneuro0300
Abstract
Narcolepsy is a neurological disorder that is characterized by excessive daytime sleepiness and cataplexy--a loss of muscle tone generally triggered by certain strong emotions with sudden onset. The underlying cause of most cases of human narcolepsy is a loss of neurons that produce hypocretin (Hcrt, also known as orexin). These cells normally serve to drive and synchronize the activity of monoaminergic and cholinergic cells. Sleepiness results from the reduced activity of monoaminergic, cholinergic and other cells that are normally activated by Hcrt neurons, as well as from the loss of Hcrt itself. Cataplexy is caused by an episodic loss of activity in noradrenergic cells that support muscle tone, and a linked activation of a medial medullary cell population that suppresses muscle tone. Current treatments for narcolepsy include stimulants to combat sleepiness and antidepressants to reduce cataplexy. Sodium oxybate produces both reductions in cataplexy and improved waking alertness. Future treatments are likely to include Hcrt or Hcrt agonists to reverse the underlying neurochemical deficit.Keywords
This publication has 53 references indexed in Scilit:
- Neuronal Activity in Narcolepsy: Identification of Cataplexy-Related Cells in the Medial MedullaScience, 2006
- Discharge of Identified Orexin/Hypocretin Neurons across the Sleep-Waking CycleJournal of Neuroscience, 2005
- The Wake-Promoting Hypocretin/Orexin Neurons Change Their Response to Noradrenaline after Sleep DeprivationJournal of Neuroscience, 2005
- Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onsetAnnals of Neurology, 2004
- Treatment with immunosuppressive and anti-inflammatory agents delays onset of canine genetic narcolepsy and reduces symptom severityExperimental Neurology, 2004
- Expression of a Poly-Glutamine-Ataxin-3 Transgene in Orexin Neurons Induces Narcolepsy–Cataplexy in the RatJournal of Neuroscience, 2004
- Relationship between CSF hypocretin levels and hypocretin neuronal lossExperimental Neurology, 2003
- Hypothalamic orexin (hypocretin) neurons express vesicular glutamate transporters VGLUT1 or VGLUT2Journal of Comparative Neurology, 2003
- Sniffing neuropeptides: a transnasal approach to the human brainNature Neuroscience, 2002
- Autoimmune Diseases: The Failure of Self ToleranceScience, 1990